← All claims

Sweeteners · Metabolic & Cardiometabolic

saccharin does not increase blood glucose

Strong support Sweeteners

Part of: • saccharin

RefutedContestedStrong support
consensus score 0.70

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

4 support 0 contradict 0 tested null 1 mixed · 5 sources, 4 independent groups

What the evidence shows

Acutely, saccharin is glycemically inert — it delivers no digestible carbohydrate and RCTs/meta-analyses show no meaningful postprandial glucose or insulin rise. (Its debated metabolic effect is on longer-term glucose tolerance via the microbiome — a separate claim — not on acute blood sugar.)

The evidence (7)

SourceGradeStanceQualityFinding
Ahmad SY, Azad MB, Friel J, MacKay D
2019 · Curr Opin Clin Nutr Metab Care
observational supports low Review: NNS incl. saccharin do not adversely affect acute glycemic control.
Zhang R, Noronha JC, Khan TA, McGlynn N, Back S, Grant SM, Kendall CWC, Sievenpiper JL
2023 · Nutrients
meta-analysis supports low Network MA of NNS beverages: no meaningful acute glycemic/endocrine rise.
Iizuka K
2022 · Nutrients
observational mixed low Review: human meta-analyses find artificial sweeteners incl. saccharin have no effect on glycemic control.
McGlynn ND, Khan TA, Wang L, Zhang R, Chiavaroli L, Au-Yeung F, Lee JJ, Noronha JC, Comelli EM, Blanco Mejia S, Ahmed A, Malik VS, Hill JO, Leiter LA, Agarwal A, Jeppesen PB, Rahelic D, Kahleová H, Salas-Salvadó J, Kendall CWC, Sievenpiper JL
2022 · JAMA Netw Open
meta-analysis mixed moderate RCT: NNS vs sugar — no adverse glycemic response.
Nichol AD, Holle MJ, An R
2018 · Eur J Clin Nutr
meta-analysis supports moderate MA of NNS RCTs: no significant acute glycemic impact (incl. saccharin).
Rathaus M, Azem L, Livne R, Ron S, Ron I, Hadar R, Efroni G, Amir A, Braun T, Haberman Y, Tirosh A
2024 · Mol Metab
animal supports moderate Long-term NNS metabolic study: acute glycemic neutrality but possible longer-term effects (context).
Orku SE, Suyen G, Bas M
2023 · Nutrition
RCT supports moderate RCT: regular low/no-calorie sweeteners did not impair glucose tolerance.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.